Phase 2 COVID Clinical Trials
55 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 55 trials
Recruiting
Phase 2
Arginine Replacement Therapy in COVID-19
COVID-19
Emory University21 enrolled1 locationNCT05855330
Recruiting
Phase 1Phase 2
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)
Post COVID-19 ConditionLong COVIDLong COVID Syndrome+2 more
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia90 enrolled1 locationNCT06766825
Recruiting
Phase 2Phase 3
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Long COVIDSmell DysfunctionOlfactory Disorder
Medical University of South Carolina145 enrolled1 locationNCT05855369
Recruiting
Phase 2
A Study to Assess Anktiva in Patients With Long Covid-19.
Long COVID
ImmunityBio, Inc.20 enrolled1 locationNCT07108036
Recruiting
Phase 2
DAOIB for the Treatment of Brain Fog
Long COVID
Chang Gung Memorial Hospital40 enrolled1 locationNCT05764538
Recruiting
Phase 2Phase 3
Taurine Supplementation in Long COVID
Long COVID
University of Alberta300 enrolled5 locationsNCT06721949
Recruiting
Phase 2
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
COVID-19SARS-CoV Infection
University of Texas Southwestern Medical Center112 enrolled1 locationNCT05886816
Recruiting
Phase 2
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center80 enrolled1 locationNCT05672355
Recruiting
Phase 2
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 2
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
COVID-19Immunodeficiency
ANRS, Emerging Infectious Diseases256 enrolled18 locationsNCT05587894
Recruiting
Phase 2
NE3107 in Adults With Neurological Symptoms of Long COVID
Long COVID
BioVie Inc.208 enrolled20 locationsNCT06847191
Recruiting
Phase 2
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
COVID-19
University of Oxford3,800 enrolled7 locationsNCT05041907
Recruiting
Phase 2
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients
COVID-19Immunodeficiency
Calmy Alexandra256 enrolled4 locationsNCT07406217
Recruiting
Phase 2
A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol
COVID-19 Infection
McMaster University350 enrolled2 locationsNCT06381739
Recruiting
Phase 2
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Post-Acute COVID-19 SyndromePostural Tachycardia Syndrome (POTS)
Vanderbilt University Medical Center50 enrolled1 locationNCT07189936
Recruiting
Phase 2Phase 3
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
Post-Acute COVID-19 SyndromeLong COVIDPost-Acute COVID-19
Hellenic Institute for the Study of Sepsis182 enrolled24 locationsNCT05926505
Recruiting
Phase 2
A Nasal Treatment for COVID-19
HealthyCOVID-19
Indiana University40 enrolled1 locationNCT05799521
Recruiting
Phase 2
Immunoadsorption in Autoimmune Long COVID
Long COVID-19 SyndromeLong COVIDLong COVID Syndrome
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)70 enrolled1 locationNCT07316127
Recruiting
Phase 2
Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
COVID-19
CastleVax Inc.200 enrolled2 locationsNCT07215520